Understanding how certain bacteria evolve and defend against viruses
The contribution of novel cytidine deaminase regulatory systems to bacterial evolution
This study is looking at how certain genes help cholera bacteria survive and adapt, especially when they face viruses, to better understand how these germs behave and resist threats, which could be helpful for anyone interested in fighting cholera.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan State University NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-11004130 on NIH RePORTER |
What this research studies
This research investigates the role of novel genetic elements in the evolution of the cholera-causing bacteria, Vibrio cholerae. It focuses on two specific genetic islands that may be crucial for the bacteria's ability to survive and adapt, particularly in the context of viral infections. By studying the regulatory systems of a newly discovered enzyme, the research aims to uncover how these bacteria manage their genetic material and respond to threats. This could provide insights into bacterial behavior and resistance mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals affected by cholera or other bacterial infections.
Not a fit: Patients with viral infections that do not involve bacterial co-infections may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for combating bacterial infections and improving public health outcomes.
How similar studies have performed: Previous research has shown success in understanding bacterial evolution and defense mechanisms, suggesting that this approach may yield valuable insights.
Where this research is happening
East Lansing, United States
- Michigan State University — East Lansing, United States (Active)
Researchers
- Principal investigator: Waters, Christopher M — Michigan State University
- Study coordinator: Waters, Christopher M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.